Estudos em progresso de Microsferas de resina SIR-Spheres® Y-90 no tratamento de  HCC

Título Configuração Patrocinador Identificação do Estudo Grupo(s) de tratamento N Local
SIRveNIB
http://www.sirvenib.com/
Estudo para comparar SIRT versus sorafenib em carcinomas hepatocelulares avançados locais
Carcinoma Hepatocelular Estudo de grupo colaborativo NCT01135056 Sorafenib versus Microsferas de resina SIR-Spheres Y-90 360 Asia-Pacifico
SARAH
Sorafenib versus radioembolização em carcinoma hepatocelular avançado carcinoma
Carcinoma Hepatocelular Estudo de grupo colaborativo NCT01482442 Sorafenib versus Microsferas de resina SIR-Spheres Y-90 460 França
SORAMIC
www.soramic.de Sorafenib e micro-terapia guiada por ressonância magnética aumentada por Primovist em pacientes com câncer inoperável no fígado.
Carcinoma Hepatocelular Iniciado pelo Investigador NCT01126645 Sorafenib versus Microsferas de resina SIR-Spheres Y-90 > Sorafenib 420 Europa

 



Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×